Goro Sashida

4.1k total citations
88 papers, 2.7k citations indexed

About

Goro Sashida is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Goro Sashida has authored 88 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 54 papers in Molecular Biology and 25 papers in Genetics. Recurrent topics in Goro Sashida's work include Acute Myeloid Leukemia Research (52 papers), Epigenetics and DNA Methylation (22 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Goro Sashida is often cited by papers focused on Acute Myeloid Leukemia Research (52 papers), Epigenetics and DNA Methylation (22 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Goro Sashida collaborates with scholars based in Japan, United States and China. Goro Sashida's co-authors include Kazuma Ohyashiki, Junko H. Ohyashiki, Tetsuzo Tauchi, Atsushi Iwama, Masahiko Sumi, Akihiro Nakajima, Kazuo Shin‐ya, Makiko Mochizuki‐Kashio, Motohiko Oshima and Stephen D. Nimer and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Goro Sashida

86 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Goro Sashida Japan 28 2.0k 1.1k 404 392 390 88 2.7k
Hélène Lapillonne France 22 1.5k 0.7× 905 0.8× 495 1.2× 665 1.7× 285 0.7× 57 2.7k
Tetsuzo Tauchi Japan 30 1.6k 0.8× 1.5k 1.4× 911 2.3× 418 1.1× 621 1.6× 146 3.1k
Hirohiko Shibayama Japan 25 1.0k 0.5× 783 0.7× 501 1.2× 86 0.2× 463 1.2× 123 2.2k
Akihide Yoshimi Japan 23 994 0.5× 683 0.6× 250 0.6× 80 0.2× 231 0.6× 64 1.6k
Dario Ferrero Italy 25 872 0.4× 1.0k 0.9× 488 1.2× 102 0.3× 472 1.2× 92 2.0k
Tushar D. Bhagat United States 24 1.5k 0.8× 410 0.4× 210 0.5× 122 0.3× 452 1.2× 55 2.4k
Gabriel Ghiaur United States 25 934 0.5× 725 0.7× 230 0.6× 72 0.2× 479 1.2× 87 1.9k
Margarete Zaborski Germany 20 660 0.3× 608 0.6× 346 0.9× 107 0.3× 306 0.8× 43 1.5k
Keiko Okuda Japan 24 949 0.5× 1.2k 1.1× 747 1.8× 101 0.3× 651 1.7× 67 2.6k
SJ Sharkis United States 18 779 0.4× 1.2k 1.1× 607 1.5× 115 0.3× 379 1.0× 36 2.1k

Countries citing papers authored by Goro Sashida

Since Specialization
Citations

This map shows the geographic impact of Goro Sashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Sashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Sashida more than expected).

Fields of papers citing papers by Goro Sashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goro Sashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Sashida. The network helps show where Goro Sashida may publish in the future.

Co-authorship network of co-authors of Goro Sashida

This figure shows the co-authorship network connecting the top 25 collaborators of Goro Sashida. A scholar is included among the top collaborators of Goro Sashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goro Sashida. Goro Sashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohguchi, Hiroto, Sho Kubota, Shingo Usuki, et al.. (2024). Multiple myeloma–associated DIS3 gene is essential for hematopoiesis, but loss of DIS3 is insufficient for myelomagenesis. PubMed. 1(1). 100005–100005.
2.
Kubota, Sho, Takako Yokomizo‐Nakano, Jie Bai, et al.. (2024). TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia. Leukemia. 38(6). 1275–1286. 2 indexed citations
3.
Yokomizo‐Nakano, Takako, Sho Kubota, Jie Bai, et al.. (2023). Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs. The Journal of Experimental Medicine. 220(7). 4 indexed citations
4.
Araki, Kimi, Jie Bai, Kumiko Yoshinobu, et al.. (2023). A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice. Cancer Science. 114(7). 2821–2834. 2 indexed citations
5.
Kubota, Sho, Sofiane Hamidi, Takako Yokomizo‐Nakano, et al.. (2022). HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2‐dependent manner. The FASEB Journal. 36(7). e22345–e22345. 4 indexed citations
6.
Yokomizo‐Nakano, Takako, Sho Kubota, Jie Bai, et al.. (2020). Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome. Cancer Research. 80(12). 2523–2536. 14 indexed citations
7.
Shide, Kotaro, Takuro Kameda, Ayako Kamiunten, et al.. (2020). Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms. Blood. 136(1). 106–118. 10 indexed citations
8.
Kudoh, Shinji, Sho Kubota, Tatsuya Yamada, et al.. (2019). Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Laboratory Investigation. 99(11). 1622–1635. 30 indexed citations
9.
Hayashi, Yasutaka, Susumu Goyama, Shuhei Asada, et al.. (2019). Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia. Nature Communications. 10(1). 4869–4869. 33 indexed citations
10.
Sashida, Goro, Motohiko Oshima, & Atsushi Iwama. (2019). Deregulated Polycomb functions in myeloproliferative neoplasms. International Journal of Hematology. 110(2). 170–178. 9 indexed citations
11.
Mochizuki‐Kashio, Makiko, Goro Sashida, Kazumasa Aoyama, et al.. (2015). EZH2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an EZH1-depenedent manner. Experimental Hematology. 43(9). S81–S81. 1 indexed citations
12.
Kameda, Takuro, Kotaro Shide, Ayako Kamiunten, et al.. (2015). Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms. Genomics Data. 4. 102–108. 3 indexed citations
13.
Muto, Tomoya, Goro Sashida, Motohiko Oshima, et al.. (2013). Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. The Journal of Experimental Medicine. 210(12). 2627–2639. 137 indexed citations
14.
Sashida, Goro, Narae Bae, Silvana Di Giandomenico, et al.. (2011). The Mef/Elf4 Transcription Factor Fine Tunes the DNA Damage Response. Cancer Research. 71(14). 4857–4865. 12 indexed citations
15.
Sashida, Goro, et al.. (2010). The oncogenic role of the ETS transcription factors MEF and ERG. Cell Cycle. 9(17). 3457–3459. 16 indexed citations
16.
Okabe, Seiichi, Tetsuzo Tauchi, Akihiro Nakajima, et al.. (2007). Depsipeptide (FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing Cell Lines and Cells from Patients with Chronic Myelogenous Leukemia in Blast Crisis. Stem Cells and Development. 16(3). 503–514. 29 indexed citations
17.
Ishii, Yuko, Hui‐Hua Hsiao, Goro Sashida, et al.. (2006). Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genetics and Cytogenetics. 167(2). 131–137. 9 indexed citations
18.
Sashida, Goro, Yoshikazu Ito, Akihiro Nakajima, et al.. (2003). Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia. Cancer Genetics and Cytogenetics. 141(2). 154–156. 5 indexed citations
19.
Nakajima, Akihiro, Tetsuzo Tauchi, Goro Sashida, et al.. (2003). Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia. 17(3). 560–567. 82 indexed citations
20.
Ohyashiki, Junko H., Goro Sashida, Tetsuzo Tauchi, & Kazuma Ohyashiki. (2002). Telomeres and telomerase in hematologic neoplasia. Oncogene. 21(4). 680–687. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Lapillonne Breakdown of academic impact, for papers by Tetsuzo Tauchi Breakdown of academic impact, for papers by Hirohiko Shibayama Breakdown of academic impact, for papers by Akihide Yoshimi Breakdown of academic impact, for papers by Dario Ferrero Breakdown of academic impact, for papers by Tushar D. Bhagat Breakdown of academic impact, for papers by Gabriel Ghiaur Breakdown of academic impact, for papers by Margarete Zaborski Breakdown of academic impact, for papers by Keiko Okuda Breakdown of academic impact, for papers by SJ Sharkis
Rankless by CCL
2026